Modelling trajectories of parentally reported and physician‐confirmed atopic dermatitis in a birth cohort study. (1st February 2022)

• Record Type: Journal Article
• Authors: Nakamura, T.; Haider, S.; Fontanella, S.; Murray, C.S.; Simpson, A.; Custovic, A.
• Is Part Of: British journal of dermatology. Volume 186:Number 2(2022)
• Page Start: 274
• Page End: 284
• Publication Date: 2022-02-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.20767
• Languages: English
• ISSNs: 0007-0963

Abstract

Summary: Background: In a population‐based birth cohort, we aimed to identify longitudinal trajectories of atopic dermatitis (AD) during childhood using data from different sources (validated questionnaires and healthcare records). We investigated the impact of different AD definitions on such trajectories and their relationships with various risk factors. Methods: Of the 1184 children born into the study, 1083 had information on current AD for at least three follow‐ups from birth to age 11 years and were included in the analysis for parentally reported AD (PRAD). Data were transcribed from healthcare records for 916 of 1184 children for the analysis of doctor‐diagnosed AD (DDAD). We also derived a composite definition of AD (CDAD) (at least two of the following: PRAD, DDAD, current use of AD treatment). Using latent class analysis (LCA), we determined longitudinal profiles of AD using the three definitions. Filaggrin ( FLG ) genotype data were available for 803 white participants. Results: For PRAD, LCA identified four AD classes ('no AD', 'persistent', 'early‐onset remitting' and 'late‐onset'). For DDAD and CDAD, the optimal number of phenotypes was three ('no AD', 'persistent' and 'early‐onset remitting'). Although AD classes at population level appeared similar in different models, a considerable proportion of children ( n = 485, 45%) moved between classes. The association with FLG genotype, atopic diseases and early‐life risk factors was inconsistent across different definitions, but the association with oral food challenge‐confirmed peanut allergy was similar, with a nine‐ to 11‐fold increase among children in the persistent AD class. In a CDAD model, compared with the early‐onset remitting class, those with persistent AD were significantly more likely to have (at age 3 years) moderate/severe AD, polysensitization and current wheeze, and were less likely to have been breastfed. Conclusions: Standardized composite definitions of AD may help to define AD cases with more precision and identify more consistent long‐term trajectories.